It would be of interest in the future to determine if overexpression or silencing of CYP1B1 affects eicosanoid levels in prostate cancer tissue and how individual eicosanoids affect caspase-1 expression and activity in vitro and in vivo. The gene discussed is CASP1; the disease is prostate cancer.